Corcept CFO Atabak Mokari sells common shares worth $3.22 million
Share
Listen to the news
Corcept CFO Atabak Mokari sells common shares worth $3.22 million
  • Corcept CFO Atabak Mokari exercised options for 40,000 common shares at USD 19.26 on June 15, 2026.
  • Sold 39,999 common shares the same day at weighted-average prices of about USD 80.02 to USD 82.45.
  • Held 16,130 common shares after the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-274224), on June 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending